Duchenne Muscular Dystrophy (DMD) is a neuromuscular disorder characterized by the dysfunction of the dystrophin protein which results in a spectrum of severe clinical manifestations, including delayed motor milestones, the eventual loss of independent ambulation, and the development of life limiting cardiac and respiratory complications (1). This evidence concerns the gene DMD and Duchenne muscular dystrophy.